Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial

Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial have?

Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial has 47 citations in the OpenAlex counts ScholarIQ stores.

When was Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial published?

Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial has 2023 year in the ScholarIQ index.

What is the open-access status of Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial?

Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial has closed oa status in the ScholarIQ index.

What is the DOI of Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial?

The DOI for Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial is on the source record.

What is the PMID of Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial?

The PMID for Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial is on the source record.

What is the OpenAlex record for Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial?

The OpenAlex for Obesity, Cardiovascular Disease, and the Promising Role of Semaglutide: Insights from the SELECT Trial is on the source record.